Skip to main content

Peer Review reports

From: Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer

Original Submission
7 Oct 2018 Submitted Original manuscript
17 Dec 2018 Reviewed Reviewer Report - Osamu Nishiyama
10 Jan 2019 Reviewed Reviewer Report - Jason Lobo
5 Feb 2019 Author responded Author comments - Shohei Hamada
Resubmission - Version 2
5 Feb 2019 Submitted Manuscript version 2
5 Mar 2019 Reviewed Reviewer Report - Osamu Nishiyama
16 Mar 2019 Author responded Author comments - Shohei Hamada
Resubmission - Version 3
16 Mar 2019 Submitted Manuscript version 3
Publishing
24 Mar 2019 Editorially accepted
2 Apr 2019 Article published 10.1186/s12890-019-0838-2

You can find further information about peer review here.

Back to article page